Our previous report demonstrated that APC could ameliorate metabolic syndrome by suppressing CREB/CRTC2− mediated gluconeogenesis and the transcription of sterol regulatory element−binding protein (SREBP) in obese mice [8]. This evidence concerns the gene CRTC2 and metabolic syndrome.